ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Aphenylbarbit 15 mg/50 mg/100 mg, Tabletten:Streuli Pharma AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
N03AA02 - PhenobarbitalATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N03 - Antiepileptics
 
N03A - Antiepileptics

This group comprises preparations used in the treatment of epilepsy and related conditions (e.g. seizures).
Combined preparations are classified at separate 5th levels using the corresponding 50-series.
The group is subdivided according to chemical structure.

The DDDs for the antiepileptics are based on combination therapy.

N03AA - Barbiturates and Derivatives

Barbiturates used mainly as hypnotics/sedatives are classified in N05C - Hypnotics and sedatives.
Phenobarbital, which is used both as an antiepileptic and as a sedative, is classified in this group.
Combinations with phenytoin are classified in N03AB.

N03AA02 - Phenobarbital
DoseRoute of administrationNote
 P 
 O 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home